Data licensing
The legal dataset and the trials registry as structured data, on a set refresh cadence, with a citable review date.
Typically: Insurers, health systems, state agencies, law firms, investors
Licensed data, commissioned analysis, and collaboration — for teams that have to cite a source and need it to still be right in six months.
The short answer
We license our datasets, write commissioned briefings, and collaborate with research institutions. Every figure traces to a primary source: 15 training programs from the state regulator’s approved list, 133 recruiting trials from ClinicalTrials.gov, 2 of 51 jurisdictions checked against the statute. That sourcing is what a licensee is buying.
What we do
Every client here needs the research to survive scrutiny. So does every reader.
The legal dataset and the trials registry as structured data, on a set refresh cadence, with a citable review date.
Typically: Insurers, health systems, state agencies, law firms, investors
Written analysis on one question. What a state's program permits, how a trial's endpoints compare with its coverage, what an FDA action changes. Delivered to you rather than published.
Typically: Policy teams, benefits designers, journalists on longer projects
Co-maintaining a dataset, contributing to a review, or opening the registry to a research group. Free where the output is public.
Typically: Universities, research centers, non-profits
Support from an organization with nothing to sell our readers. Disclosed on the page, editorially separate, and ours to end.
Typically: Foundations, grant-making bodies, professional associations
Tell us what you need and roughly when. This reaches a person, not a queue, and you will get a real answer — including a no, with the reason, if that is the answer.
Three things worth saying up front, because they save everyone time. We will not sign anything that gives a funder approval over what we publish. We will always disclose a commercial relationship on the pages it could touch. And if we think the work would compromise the site, we will say so and tell you why rather than quoting a price we hope you decline.
Or write directly to [email protected].
Common questions